Filing Details
- Accession Number:
- 0000950138-17-000319
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-14 08:40:00
- Reporting Period:
- 2017-03-10
- Filing Date:
- 2017-03-14
- Accepted Time:
- 2017-03-14 08:40:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1567892 | Mallinckrodt Plc | MNK | Pharmaceutical Preparations (2834) | 981088325 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578368 | K Matthew Harbaugh | 675 Mcdonnell Blvd. Hazelwood MO 63042 | Exec. Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2017-03-10 | 600 | $49.19 | 76,085 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price represents a weighted average. The shares were purchased in multiple transactions at prices ranging from $49.18 to $49.22, inclusive. Mr. Harbaugh will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares sold at each price within the range.
- Includes 156 shares acquired on December 31, 2016, under the Mallinckrodt employee stock purchase plan.
Billionaire Hedge Funds
